ArsenalBio's Co-Founder & CEO Ken Drazan talks about engineering the next generation of T-cell...
He describes the ArsenalBio's "CITE" platform, which allows it to make heterogenous cells by inserting modifications all in the same place. Plus, writing in logic gating, harnessing shRNA, and more....
biotechtv.com